Materials Healthcare Sector

Bright Minds Biosciences

Market Cap: CA$313.2m

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Aquestive Therapeutics

Market Cap: US$225.5m

Operates as a pharmaceutical company in the United States and internationally.

Cipher Pharmaceuticals

Market Cap: CA$309.9m

Operates as a specialty pharmaceutical company in Canada.

Lexicon Pharmaceuticals

Market Cap: US$222.8m

A biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease.

ProKidney

Market Cap: US$221.3m

A clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States.

Astria Therapeutics

Market Cap: US$221.2m

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States.

Dimerix

Market Cap: AU$339.9m

A biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia.

Monopar Therapeutics

Market Cap: US$217.4m

A clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.

Tevogen Bio Holdings

Market Cap: US$217.0m

A clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders.

Annexon

Market Cap: US$216.1m

A clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.

MediWound

Market Cap: US$215.0m

A biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally.

OptimizeRx

Market Cap: US$214.7m

Operates as a digital healthcare technology company.

Actuate Therapeutics

Market Cap: US$214.5m

A clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States.

Medical Facilities

Market Cap: CA$296.1m

Through its subsidiaries, owns and operates specialty surgical hospitals and ambulatory surgery center in the United States.

Solid Biosciences

Market Cap: US$209.3m

Develops therapies for neuromuscular and cardiac diseases in the United States.

VitaSpring Biomedical

Market Cap: US$207.0m

Focuses on the development of drugs of cell medicine.

enGene Holdings

Market Cap: US$205.9m

Through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer.

Tango Therapeutics

Market Cap: US$204.9m

A precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need.

Performant Healthcare

Market Cap: US$204.4m

Provides audit, recovery, and analytics services in the United States.

Design Therapeutics

Market Cap: US$204.4m

A clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States.

Bioventix

Market Cap: UK£150.2m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

BioStem Technologies

Market Cap: US$200.4m

A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.

Integrated Diagnostics Holdings

Market Cap: US$200.0m

Operates as a consumer healthcare company that provides medical diagnostics services to patients.

Monash IVF Group

Market Cap: AU$305.9m

Provides assisted reproductive and specialist women imaging services in Australia and Malaysia.

SOPHiA GENETICS

Market Cap: US$195.8m

Operates as a cloud-native software technology company in the healthcare space.

ADC Therapeutics

Market Cap: US$195.4m

Provides antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid tumors.

ME Therapeutics Holdings

Market Cap: CA$269.8m

A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.

Codexis

Market Cap: US$193.9m

Provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.

4basebio

Market Cap: UK£144.1m

Engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally.

Cardiff Oncology

Market Cap: US$192.9m

A clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers.

UroGen Pharma

Market Cap: US$192.3m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

Orthocell

Market Cap: AU$297.6m

A regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia, the United States, the United Kingdom, and the European Union.

Inhibrx Biosciences

Market Cap: US$190.5m

A clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions.

OraSure Technologies

Market Cap: US$190.4m

Develops, manufactures, markets, sells, and distributes diagnostic products, specimen collection devices, and other diagnostic products in the United States, Europe, Africa, and internationally.

biote

Market Cap: US$189.7m

Operates in practice-building business within the hormone optimization space.

Born

Market Cap: US$188.8m

Does not have significant operations.